Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis
PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment
180
Participants
Timeline
Start Date
March 18, 2021
Primary Completion Date
June 18, 2026
Study Completion Date
June 18, 2026
Conditions
EndometriosisAdenomyosisInfertility, Female
Interventions
DRUG
GnRH agonist
One or two intramuscular injections of Decapeptyl 3 mg
Trial Locations (1)
92150
RECRUITING
Hopital Foch, Suresnes
All Listed Sponsors
lead
Hopital Foch
OTHER
NCT04356664 - Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis | Biotech Hunter | Biotech Hunter